TY  - GEN 
AU  - Simon, Iris
AU  - Sanchez Manas, Jose Manuel
AU  - Perales, Sonia
AU  - Martinez-Navajas, Gonzalo
AU  - Ceron-Hernandez, Jorge
AU  - Real Luna, Pedro José
PY  - 2025
UR  - https://hdl.handle.net/10481/104753
AB  - The treatment of choice for prostate cancer is androgen deprivation (ADT) and novel hormonal agents such as Abiraterone, Enzalutamide, or Apalutamide. Initially, this therapy is highly effective, but a significant challenge arises as most patients...
LA  - eng
KW  - Prostate cancer
KW  - androgen deprivation therapy
KW  - castration-resistant prostate cancer
KW  - abiraterone
KW  - enzalutamide
KW  - apalutamide
TI  - Phenotypic Plasticity and Androgen Receptor Bypass Drive Cross-Resistance to Apalutamide in Castration-Resistant Prostate Cancer Cell Models
DO  - https://doi.org/10.3390/ijms26135939
ER  -